Cellebrite DI (CLBT) Competitors $19.72 -0.46 (-2.28%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends CLBT vs. DOCU, DT, TWLO, DUOL, CYBR, MBLY, BSY, MNDY, PAYC, and OKTAShould you be buying Cellebrite DI stock or one of its competitors? The main competitors of Cellebrite DI include DocuSign (DOCU), Dynatrace (DT), Twilio (TWLO), Duolingo (DUOL), CyberArk Software (CYBR), Mobileye Global (MBLY), Bentley Systems (BSY), monday.com (MNDY), Paycom Software (PAYC), and Okta (OKTA). These companies are all part of the "computer software" industry. Cellebrite DI vs. DocuSign Dynatrace Twilio Duolingo CyberArk Software Mobileye Global Bentley Systems monday.com Paycom Software Okta Cellebrite DI (NASDAQ:CLBT) and DocuSign (NASDAQ:DOCU) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, community ranking, earnings, risk, valuation and profitability. Does the MarketBeat Community prefer CLBT or DOCU? DocuSign received 380 more outperform votes than Cellebrite DI when rated by MarketBeat users. However, 63.33% of users gave Cellebrite DI an outperform vote while only 59.04% of users gave DocuSign an outperform vote. CompanyUnderperformOutperformCellebrite DIOutperform Votes3863.33% Underperform Votes2236.67% DocuSignOutperform Votes41859.04% Underperform Votes29040.96% Does the media prefer CLBT or DOCU? In the previous week, DocuSign had 9 more articles in the media than Cellebrite DI. MarketBeat recorded 17 mentions for DocuSign and 8 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 0.89 beat DocuSign's score of 0.88 indicating that Cellebrite DI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellebrite DI 4 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DocuSign 12 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, CLBT or DOCU? Cellebrite DI has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500. Comparatively, DocuSign has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Which has better earnings and valuation, CLBT or DOCU? DocuSign has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than DocuSign, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCellebrite DI$325.11M12.49-$81.10M-$1.55-12.72DocuSign$2.86B5.90$73.98M$4.7417.52 Is CLBT or DOCU more profitable? DocuSign has a net margin of 34.56% compared to Cellebrite DI's net margin of -82.28%. Cellebrite DI's return on equity of 122.59% beat DocuSign's return on equity.Company Net Margins Return on Equity Return on Assets Cellebrite DI-82.28% 122.59% 14.49% DocuSign 34.56%16.18%6.47% Do analysts recommend CLBT or DOCU? Cellebrite DI currently has a consensus target price of $20.29, suggesting a potential upside of 2.87%. DocuSign has a consensus target price of $65.80, suggesting a potential downside of 20.75%. Given Cellebrite DI's stronger consensus rating and higher probable upside, equities analysts clearly believe Cellebrite DI is more favorable than DocuSign.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cellebrite DI 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00DocuSign 2 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders have more ownership in CLBT or DOCU? 45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 77.6% of DocuSign shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by company insiders. Comparatively, 1.7% of DocuSign shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryCellebrite DI beats DocuSign on 10 of the 18 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLBT vs. The Competition Export to ExcelMetricCellebrite DIPrepackaged software IndustryBusiness SectorNASDAQ ExchangeMarket Cap$4.06B$25.44B$6.98B$8.84BDividend YieldN/A2.26%2.86%4.09%P/E Ratio-12.7297.8529.6317.83Price / Sales12.4913.84582.56158.41Price / Cash69.5887.8026.6936.29Price / Book13.608.955.116.50Net Income-$81.10M$444.73M$124.16M$226.22M7 Day Performance11.41%7.31%7.00%4.03%1 Month Performance10.11%12.83%16.04%4.92%1 Year Performance132.00%29.20%34.59%29.30% Cellebrite DI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLBTCellebrite DI0.8469 of 5 stars$19.72-2.3%$20.29+2.9%+132.0%$4.06B$325.11M-12.721,008DOCUDocuSign4.3608 of 5 stars$80.18+1.7%$63.40-20.9%+96.5%$16.27B$2.76B16.636,840Analyst ForecastDTDynatrace4.953 of 5 stars$52.55+2.9%$61.50+17.0%+6.8%$15.69B$1.43B92.894,700Positive NewsTWLOTwilio4.3808 of 5 stars$101.95+3.6%$83.70-17.9%+66.6%$15.64B$4.15B-39.745,867DUOLDuolingo3.6809 of 5 stars$341.93+3.3%$331.33-3.1%+61.0%$15.04B$531.11M186.85600CYBRCyberArk Software2.8906 of 5 stars$329.15+3.9%$328.37-0.2%+66.9%$14.34B$751.89M1,173.752,140Positive NewsMBLYMobileye Global2.9495 of 5 stars$17.34+2.5%$23.14+33.4%-58.6%$14.07B$2.08B-4.753,700BSYBentley Systems4.6142 of 5 stars$47.85+2.5%$59.50+24.3%-6.9%$13.91B$1.23B43.115,200Positive NewsMNDYmonday.com2.8735 of 5 stars$276.26+6.2%$310.81+12.5%+62.6%$13.34B$729.70M673.801,168Analyst ForecastPositive NewsPAYCPaycom Software4.7389 of 5 stars$226.90+3.2%$193.67-14.6%+29.8%$13.08B$1.69B26.437,308Positive NewsOKTAOkta4.9193 of 5 stars$75.45+2.4%$98.30+30.3%+6.5%$12.82B$2.26B-89.825,908Analyst ForecastHigh Trading Volume Related Companies and Tools Related Companies DocuSign Alternatives Dynatrace Alternatives Twilio Alternatives Duolingo Alternatives CyberArk Software Alternatives Mobileye Global Alternatives Bentley Systems Alternatives monday.com Alternatives Paycom Software Alternatives Okta Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLBT) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellebrite DI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
